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Of 10 McAbs previously shown to bind to a colonic carcinoma membrane preparation in a radioimmunoassay, 7 show specific staining when tested by indirect immunofluorescence on crysotat sections of colonic tissue. Three of these 7 show activity on both normal and malignant colonic epithelium, and the remaining 4 stain normal epithelium, with little or no activity on malignant tissue. In the indirect immunofluorescent and immunoperoxidase techniques on paraffin sections of the same material, only 2 McAbs retain activity; one detects an antigen in colonic mucus, and the other recognises an antigen which is sparse on normal colonic epithelium and abundant on colonic tumours.
We conclude that screening of McAbs on frozen tissue sections, using indirect immunofluorescence, is a useful adjunct to conventional screening methods, e.g. binding to membrane preparations and/or cell lines in a radioimmunoassay. These techniques distinguish McAbs with similar binding values in conventional assays, identify their activity on a wide range of normal and malignant tissues, demonstrate antigens that are lost or gained in malignant transformation and finally assist in the selection of McAbs for further extensive study before possible clinical use.
MONOCLONAL ANTIBODIES (McAbs) produced by the cell-fusion technique (Kohler & Milstein, 1975) are replacing conventional antisera in many areas of basic and applied research, and have provided new tools for serological comparison of normal and malignant tissues. Several strategies are used to make McAbs for this comparison, and, although the fusion protocols are now fairly well established (Galfre & Milstein, 1981) Indirect immunofluorescent assays were performed on frozen sections of normal and malignant colonic epithelium. The essential steps of the present method are shown in Table 1 . Five-micron sections were cut at -20°C in a cryostat (Brights), placed on multiwell slides (Hendley-Essex) and airdried. Additional sections were cut and stored unfixed at -20°C, either in or out of a dessicator, for up to one month. Comparative studies using unfixed material, fixation with 950o ethanol at 4°C for 10 min, acetone at 4°C for 10 min and 50 formol saline for 5 or 10 min, were performed. Antibody-free medium (Dulbecco's Modified Eagle's medium + 10% foetal calf serum) and phosphatebuffered saline (Dulbecco "A" tabs-Oxoid) were used as negative controls. Slides were examined with a Zeiss fluorescent microscope and activity recorded on Kodak Tri X Pan Film (ASA 400) using an M35 Zeiss camera.
The method for indirect immunofluorescence on paraffin sections was as in Table I  ( Step 3 onwards). Sections were previously Three McAbs (YPC 1/1.1, YPC 2/9.12 and YPC 2/13.14) stained normal colonic epithelium in all samples but had little or no activity on colonic tumours; e.g. YPC 2/13.14 in Fig. la . Although the 3 yielded a similar amount of binding in the membrane assay (Table III) , on the tissue sections there were distinct and recognizable differences amongst them either in the distribution of staining on the individual cells or in the pattern of activity over the whole epithelial surface. In general the pattern of activity for each McAb was consistent on the 4 specimens examined; however, one McAb (YPC 2/9.12) showed little activity on one of the specimens of normal colon.
One antibody (YPC 1/3.12) was localized to the smooth-muscle layers of the bowel wall-both the muscularis mucosae (Fig. lb) and the outer muscular coats of colon. It was also present in the walls of blood vessels. This activity was neither species-specific (being present in the gut and blood vessels of the mouse, chicken and frog) nor organ-specific (being present in chicken gizzard) (de Mattos, unpublished) .
The 3 McAbs YPC 2/12.1, YPC 2/38.9 and YPC 2/44.3 stained both normal and malignant tissue, but again each had its individual and recognizable pattern of activity. YPC 2/38.9 (Fig. 1c) (Fig. 2a) . However, as is shown in Fig. 2b & Fig. 3c & d , the same fields as Fig. 3a & b . Although the patterns of activity with YPC 2/12.1 and YPC 2/44.3 were similar on both frozen and paraffin sections, the morphological detail was better on the latter, particularly using the indirect immunoperoxidase technique.
An extension of these studies using indirect immunoperoxidase staining has shown activity with McAb YPC 2/12.1 on all of 30 colonic tumours of varying degrees of differentiation and from all parts of the large bowel. Metastatic deposits in regional lymph nodes were also detected. McAb YPC 2/44.3 shows activity on normal bronchial epithelium but not normal gastric epithelium, except in areas showing intestinal metaplasia (unpublished).
DISCUSSION
Many attempts are being made to produce McAbs that recognize antigens present on the surface of malignant cells, but not their normal counterparts. In general, cultured malignant cell lines are being used to elicit and detect these antibodies. Although some of them appear to be tumour-specific at present (Colcher et al., 1981) many others have been found, on further study, to react with cells other than the tumour cell (Koprowski et al., 1978; Dippold et al., 1980; Brown et al., 1981) . Clearly, testing the specificity of individual McAbs, particularly for crossreactions with normal tissue, is of the utmost importance prior to their use in clinical situations: e.g. targeting of radioisotopes, chemotherapeutic agents or toxins (Lennox, 1982; Lennox & Sikora, 1982 (Fogh & Trempe, 1975) and LS174T (Tom et al., 1976) and so had been retained. It is likely, since their binding to these cell lines is also weak, that these 3 McAbs were incorredtly selected. It is also possible that their antigens did not survive formol-saline fixation, though none of them was active on unfixed tissue or tissue fixed with ethanol or acetone. The activity of one McAb (YPC 1/3.12) was lost after fixation with ethanol or acetone but survived formol saline.
Storage of frozen sections after airdrying, either in or out of a dessicator at -20°C, for up to one month, did not result in antigenic loss. Indeed, further studies in progress suggest that many of the antigens recognized are still present on sections after 6 months' storage.
Our experience with a parallel study of frozen and paraffin-embedded material using indirect immunofluorescence confirms that many antigens are lost during paraffin embedding. Of the 7 McAbs positive on cryostat sections, 5 were negative on paraffin sections. We compared frozen sections of colonic tissue with routinely fixed paraffin-embedded specimens of the same tissue, processed by the hospital pathology department, to determine how useful these standard blocks would be for histological screening. It is apparent that many potentially useful McAbs, directed to antigenic determinants present on normal and malignant tissues and also to antigens lost by malignant tissue (e.g. YPC 2/13.14) would have been discarded if screening had been limited to paraffin blocks. We conclude that histological screening on frozen sections yields maximum information at the outset. If McAbs are being produced in order to conduct retrospective studies on routinely fixed paraffin-embedded material, they should be screened at an early stage for activity on such tissue.
The screening of fusion products for some desired activity is a time-consuming step in McAb production. Techniques have to be quick, simple and reliable. We feel that there is a place for the introduction of histological screening at an early stage in the production of McAbs. These methods can demonstrate the distribution of antigens on normal and malignant tissues, and, by screening on a wide variety of tissues, reveal possible cross-reactivity. The techniques also serve to distinguish between antibodies which have similar binding values in the conventional screening systems using cell lines and membrane preparations. Moreover, they are especially good for revealing antigenic loss in malignant transformation. Detection of such losses might be turned to good advantage in the early diagnosis of malignant disease. Finally, the possible clinical use of McAbs as carriers of toxic agents (Olsnes, 1981) demands that more be learnt of the specificity of individual McAbs, particularly their cross-reactivity with a wide variety of normal tissues, and for this purpose there is at present no generally available substitute for histological screening.
